KROS - Keros Therapeutics Inc
IEX Last Trade
45.45
0.140 0.308%
Share volume: 191,272
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$45.31
0.14
0.31%
View ratios
Fiscal Date | |
---|---|
Fiscal Quarter | |
Report Date | |
Total revenue | |
Cost of revenue | |
Gross profit | |
Operating expenses | |
Selling general and admin | |
Research and development | |
Total expenses | |
Operating income | |
Ebit | |
Pretax income | |
Income tax | |
Net income basic | |
Net income |